Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chiorazzi

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Annals of Case Reports|June 28, 2024
Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic LeukemiaGonzalo Blanco, Edward Morris, Jodie L Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2013
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signalingShih-Shih Chen, Franak Batliwalla, Nichol E Holodick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal ExpansionRashmi Gupta, Xiao J Yan, Jacqueline Barrientos, et al.
Frontiers in Immunology|July 5, 2022
Soluble Fc Receptor for IgM in Sera From Subsets of Patients With Chronic Lymphocytic Leukemia as Determined by a New Mouse Monoclonal AntibodyPedram Mahmoudi Aliabadi, Ruth Teuber, Peter K Jani, et al.
Blood Cancer Journal|May 17, 2019
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation statusLauren K Shea, Kazuhito Honjo, David T Redden, et al.
Blood|April 23, 2015
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemiaXiao-jie Yan, Emilia Albesiano, Nicola Zanesi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response ProteinsRashmi Gupta, Wentian Li, Xiao J Yan, et al.
Haematologica|April 28, 2020
FcγRIIb-BCR coligation inhibits BCR signaling in chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Carolina Cuellar, et al.
British Journal of Haematology|March 30, 2011
CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cellsNino Porakishvili, Azka Memon, Ketki Vispute, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Annals of Case Reports|June 28, 2024
Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic LeukemiaGonzalo Blanco, Edward Morris, Jodie L Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2013
Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signalingShih-Shih Chen, Franak Batliwalla, Nichol E Holodick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal ExpansionRashmi Gupta, Xiao J Yan, Jacqueline Barrientos, et al.
Frontiers in Immunology|July 5, 2022
Soluble Fc Receptor for IgM in Sera From Subsets of Patients With Chronic Lymphocytic Leukemia as Determined by a New Mouse Monoclonal AntibodyPedram Mahmoudi Aliabadi, Ruth Teuber, Peter K Jani, et al.
Blood Cancer Journal|May 17, 2019
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation statusLauren K Shea, Kazuhito Honjo, David T Redden, et al.
Blood|April 23, 2015
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemiaXiao-jie Yan, Emilia Albesiano, Nicola Zanesi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response ProteinsRashmi Gupta, Wentian Li, Xiao J Yan, et al.
Haematologica|April 28, 2020
FcγRIIb-BCR coligation inhibits BCR signaling in chronic lymphocytic leukemiaRosa Bosch, Alba Mora, Carolina Cuellar, et al.
British Journal of Haematology|March 30, 2011
CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cellsNino Porakishvili, Azka Memon, Ketki Vispute, et al.
Pageof 17